MTIM
CLOV icon

Marathon Trading Investment Management’s Clover Health Investments CLOV Stock Holding History

Marathon Trading Investment Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-30,000
Closed -$400K – 392
2021
Q2 		$400K Buy
+30,000
New +$295K 0.04% 185

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Swiss National Bank
Swiss National Bank Zurich, Switzerland $191B AUM 45.21% 1-Year Est. Return
IMC Chicago
IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return

Marathon Trading Investment Management's CLOV Position: Q2 2026 in Review

Marathon Trading Investment Management held its Clover Health Investments (CLOV) position steady in Q2 2026 at 11,000 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Marathon Trading Investment Management first reported a position in CLOV in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.02M in Q2 2021. 123 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Marathon Trading Investment Management held 11,000 shares of Clover Health Investments worth $57.6K as of Q2 2026.
  • Marathon Trading Investment Management left its Clover Health Investments share count unchanged in Q2 2026.
  • Clover Health Investments made up ﹤0.01% of Marathon Trading Investment Management's portfolio in Q2 2026, its #228 holding.
  • Marathon Trading Investment Management first reported a position in Clover Health Investments in Q1 2021 and has held it in 18 quarters since.
  • Marathon Trading Investment Management's Clover Health Investments position peaked at $1.02M in Q2 2021.
  • 123 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Marathon Trading Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.